High-CSD Melanoma

subtype

Identifier: CI-CAN-00005515
Entity page: /cancer/high-csd-melanoma ↗
Edges: 6

Neighbours: 2 drugs4 trials
Drawn: 6 of 6 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
High-CSD Melanoma investigated in trials for …INVESTIGATED_IN_TRIALSderived2 of 2
→ investigated in trials for	Dinaciclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	High-CSD Melanoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants

High-CSD Melanoma studied in …STUDIED_INderived4 of 4
→ studied in	NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Lentigo Maligna Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01720407Phase 3 · completed Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Lentigo Maligna Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02775851Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Desmoplastic Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06014619active not recruiting Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Lentigo Maligna Melanoma	1	Observed	clinicaltrials	graph →

High-CSD Melanoma studied in …STUDIED_INderived4 of 4

→ studied in

NCT00937937Phase 2 · active not recruiting

Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Lentigo Maligna Melanoma

Observed

clinicaltrials

graph →

→ studied in

NCT01720407Phase 3 · completed

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Lentigo Maligna Melanoma

Observed

clinicaltrials

graph →

→ studied in

NCT02775851Phase 2 · active not recruiting

Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Desmoplastic Melanoma

Observed

clinicaltrials

graph →

→ studied in

NCT06014619active not recruiting

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Lentigo Maligna Melanoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains